Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications in Health Policy
Pnd64 - Cost-Effectiveness of Cladribine Tablets for Treatment of RRMS in the Netherlands
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Economic Burden of Acute Myocardial Infarction in Vietnam
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prs68 - Health Resource Utilization (Hru) Among Infants Diagnosed With Respiratory Syncytial Virus (Rsv) Infection in the Netherlands: A Retrospective Database Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Psy29 - Real-World Discontinuation of Biological Treatments in Moderate-To-Severe Plaque Psoriasis Over the First 5 Years of Treatment – A Literature Review of Drug Survival
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcv35 - Secondary Prevention for Cardiovascular Disease: Definition of Population and Evaluation of Outcomes Using Real World Data
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcv119 - Baseline Health Related Quality of Life in Patients Admitted by Heart Failure. Does Gender Matter?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Risk of Subsequent Migraine Events After Treating Migraine With Opioids Among Mississippi Division of Medicaid Beneficiaries
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prs48 - Cost – Effectiveness Analysis of Vilanterol/Fluticasone Furoate for Asthma Treatment in the Russian Federation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn370 - Comparisons on the Change of Psychosocial Illness Impact Across Four Cancer Survivors
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm118 - Adjustment for Subsequent Therapies Received: The Impact on Outcomes of an Economic Model of Nivolumab+ipilimumab in First Line Renal Cell Carcinoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
‹
160
161
162
163
164
165
166
›
